Scientific Sessions 2024  /  From Intervention to Prevention: Advances in Coronary and Valvular Heart Disease  /  Discussant: CLEAR SYNERGY
Logo

American Heart Association

  9
  0

Final ID:

Discussant: CLEAR SYNERGY

  • Bonaca, Marc  ( CPC Clinical Research , Aurora , Colorado , United States )
    • Author Disclosures:
    Marc Bonaca: DO have relevant financial relationships ; Research Funding (PI or named investigator):Dr. Bonaca is the Executive Director of CPC:Active (exists now) ; Research Funding (PI or named investigator):Dr. Bonaca is the Executive Director of CPC:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

From Intervention to Prevention: Advances in Coronary and Valvular Heart Disease

Sunday, 11/17/2024 , 08:00AM - 09:15AM

Late-Breaking Science

More abstracts on this topic:
From STICH to GLORIOUS: The evolution of coronary interventions

Chikwe Joanna, Farkouh Michael

Efficacy of a Glucagon-Like Peptide-1 Agonist in Patients undergoing Coronary Artery Bypass Grafting or Aortic Valve Replacement – a randomized clinical trial

Kjaergaard Jesper, Boesgaard Soeren, Kober Lars, Nilsson Jens Christian, Hassager Christian, Moeller Christian Holdflod, Wiberg Sebastian, Mikkelsen Astrid, Møller-sørensen Peter Hasse, Ravn Hanne Berg, Ravn Jesper, Olsen Peter Skov, Høfsten Dan

More abstracts from these authors:
Antithrombotic prophylaxis in patients with peripheral arterial disease

Bonaca Marc, Creager Mark

Medical Therapy and Outcomes in Patients with Critical Limb Threatening Ischemia Randomized to an Everolimus Eluting Resorbable Scaffold or Angioplasty in the LIFE-BTK Randomized Trial

Bonaca Marc, Derubertis Brian, Varcoe Ramon, Parikh Sahil

You have to be authorized to contact abstract author. Please, Login
Not Available